[A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial]

Cancer Radiother. 2017 Oct;21(6-7):491-494. doi: 10.1016/j.canrad.2017.06.007. Epub 2017 Aug 30.
[Article in French]

Abstract

The goal of treatment of metastatic prostate cancer remains palliation. The oligometastatic state could be the right time to intensify therapy by introducing metastases directed treatments. The aim of this trial was to evaluate the benefit of radiotherapy to all macroscopic metastatic sites and to the primary disease in patients with hormone sensitive oligometastatic prostate cancer.

Keywords: Cancer; Metastasis; Métastase; Prostate; Radiothérapie stéréotaxique; Stereotactic radiotherapy.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / secondary*
  • Humans
  • Lymphatic Irradiation*
  • Male
  • Neoplasm Metastasis
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / radiotherapy*
  • Radiosurgery*
  • Research Design